Search results with tag "Nonproprietary"
International Nonproprietary Names Modified - …
www.who.int2 International Nonproprietary Names Modified Contents: I. General II. INNMs for salts of basic compounds III. INNMs for salts of acidic compounds
Revised monoclonal antibody (mAb) nomenclature scheme ...
www.who.intInternational Nonproprietary Names Programme 1 Revised monoclonal antibody (mAb) nomenclature scheme International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property.
ICD–11 Fact Sheet
icd.who.int2 WHO International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognised and is public property. A nonproprietary name is also known as a generic name.
International Nonproprietary Names (INN) for biological ...
www.who.intINN Working Document 05.179 Update 2011 International Nonproprietary Names (INN) for biological and biotechnological substances (a review)
WHO Drug Dictionary
www.who.int• A source of international drug names • Substance names according to International Non Proprietary Names (INN) ... – Nonproprietary names • Multiple ingredient drugs – Trade names • First reported brand of a given ingredient combination – Nonproprietary names Magnus Wallberg, UMC.
Annex 3 WHO good manufacturing practices for ...
www.who.intInternational Nonproprietary Names (INN) for pharmaceut ical substances designated by WHO should be used when available, together with other designated names. Glossary The defi nitions given below apply to the terms used in this guide. They may have different meanings in other contexts. active pharmaceutical ingredient (API)
Nomenclature schemes for advanced therapies - who.int
www.who.intWHO International Nonproprietary Names Programme 3 During the 63rd INN Consultation in 2016, an INN-USAN-harmonized nomenclature scheme for substances for cell therapies was formally approved by the members of the INN Expert
Addendum1 to The use of stems in the selection of ...
www.who.intINN Working Document 18.430 28/02/2018 Addendum1 to "The use of stems in the selection of International Nonproprietary names (INN) for pharmaceutical
Revised monoclonal antibody (mAb) nomenclature scheme ...
www.who.intINN Working Doc. 17.416 May 2017 Distr.: GENERAL ENGLISH ONLY Revised monoclonal antibody (mAb) nomenclature scheme Geneva, 26 May 2017 Programme on International Nonproprietary Names (INN)
SUGI 24: Concomitant Medications: What a Programmer …
support.sas.cominternational level. The dictionary contains information on both single and multiple ingredient medications. Drugs are classified according to the type of drug name being entered, (i.e. proprietary/trade name, nonproprietary name, chemical name, etc.). At present, 52 countries submit medication data to the WHO Collaborating Center which is ...
WHO Expert Committee on Specifications for …
www.who.intInternational Nonproprietary Names (INN) for pharmaceutical substances Cumulative List No. 14 2011 (available on CD-ROM only) The selection and use of essential medicines Report of the WHO Expert Committee (including the Model List of Essential Medicines for Children). WHO Technical Report Series, No. 965, 2011 (249 pages)
New INN nomenclature for monoclonal antibodies
www.thelancet.comfor mAbs, and the WHO International Nonproprietary Names (INN) Programme implemented a mAb nomenclature scheme in 1991, using the stem -mab to identify this group. 1,2. In recent years, the INN Programme . received an increase in INN requests for mAbs, 3. which is making the selection of distinguishable INNs very difficult. This trend is ...
A/E/C Computer-Aided Design (CAD) Standard
www.wbdg.orgnonproprietary CAD standard that incorporates existing industry, national, and international standards and to develop data standards that ... Citation of trade names does not constitute an official endorsement or approval of the use of such commercial products.
Drug Fact Sheet: Marijuana/Cannabis - DEA
www.dea.govthe generic or International Nonproprietary Name given to THC), prescribed for the control of nausea and vomiting caused by chemotherapeutic agents used in the treatment of cancer and to stimulate appetite in acquired immune deficiency syndrome (AIDS) patients. Marinol is a Schedule III drug under the Controlled Substances Act.
Drug Fact Sheet: Marijuana/Cannabis - DEA
www.dea.govthe generic or International Nonproprietary Name given to THC), prescribed for the control of nausea and vomiting caused by chemotherapeutic agents used in the treatment of cancer and to stimulate appetite in acquired immune deficiency syndrome (AIDS) patients. Marinol is a Schedule III drug under the Controlled Substances Act.
WHO Expert Committee on Specifications The International ...
www.who.intInternational Nonproprietary Names (INN) for pharmaceutical substances Cumulative List No. 15 2013 (available on CD-ROM only) The selection and use of essential medicines Report of the WHO Expert Committee (the 18th WHO Model List of Essential Medicines and including the 4th WHO Model List of Essential Medicines for Children).
Brazilian science under continuous attack
www.thelancet.comfor mAbs, and the WHO International Nonproprietary Names (INN) Programme implemented a mAb nomenclature scheme in 1991, using the stem -mab to identify this group. 1,2. In recent years, the INN Programme . received an increase in INN requests for mAbs, 3. which is making the selection of distinguishable INNs very difficult. This trend is ...
CANNABIDIOL (CBD) Critical Review Report
www.who.intA. International Nonproprietary Name (INN) Cannabidiol B. Chemical Abstract Service (CAS) Registry Number 13956-29-1 [1] C. Other Chemical Names CBD; 2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3- benzenediol; [2] D. Trade Names Epidiolex® (in development) Arvisol® (in development) E. Street Names No data available
Nonproprietary Naming of Biological Products Guidance …
www.fda.govNonproprietary Naming of Biological Products . Guidance for Industry . U.S. Department of Health and Human Services Food and Drug Administration
Similar queries
International Nonproprietary Names Modified, Compounds, International Nonproprietary Names, ICD–11, Nonproprietary, International Nonproprietary Names (INN) for, Update, International Nonproprietary Names (INN) for biological and biotechnological substances, International, Names, International Non Proprietary Names, Nonproprietary Names, Nomenclature, Nomenclature scheme, For cell, Revised monoclonal antibody (mAb) nomenclature scheme, Committee on Specifications for, Computer-Aided Design (CAD) Standard, International Nonproprietary, Marijuana/Cannabis, Nonproprietary Naming of Biological Products, Food and Drug Administration